Suggestions
Nina Hill
Professional Background
Nina Hill is a distinguished figure in the field of Health Economics and Outcomes Research. Currently serving as the Executive Director at Halozyme Therapeutics, she plays a pivotal role in driving research initiatives that evaluate the value and efficiency of health interventions. Nina's profound expertise in economics and her ability to lead cross-functional teams has made her an influential asset in the pharmaceutical industry.
Before her tenure at Halozyme Therapeutics, Nina made significant contributions at Relypsa as the Executive Director overseeing Epidemiology and Health Economics. There, she spearheaded initiatives that aligned clinical outcomes with economic value, reinforcing the importance of health economic strategies in decision-making processes. Her insights into epidemiology facilitated better health outcomes and supported the goal of improving patient care while considering the financial implications of treatment technologies.
Nina's extensive career also includes her role as Senior Director of Health Economics and Outcomes Research at Medivation, where she directed research that formed a foundation for evidenced-based health policy and economic evaluations. At Affymax, she continued to shine as Senior Director, building a strong reputation for her analytical skills and innovative approaches towards health economic methodologies.
Earlier in her career at Genentech, Nina was pivotal first as the Principal, Global Pro Strategy and Health Economics, and also as a Senior Health Economist. Her dual experience in both strategic operations and economic analysis provided a unique blend of skills that ensured the alignment of market strategies with evolving economic landscapes.
Education and Achievements
Nina Hill's academic journey began with a strong focus on economics which she pursued at the prestigious University Of Washington, where she earned her Doctor of Philosophy in Economics. Her rigorous academic training equipped her with a solid foundation in both theoretical and applied economics, knowledge which she harnessed throughout her illustrious career.
Nina's commitment to education and research in health economics is exemplified by her involvement in various organizations and initiatives that aim to harness data for improved health outcomes. She continues to mentor emerging professionals in the field, fostering a new generation of health economists who are essential in navigating the complexities of healthcare decision-making.
Achievements
Throughout her impressive career, Nina Hill has accumulated numerous achievements that reflect her expertise and impact on health economics. She has contributed to the development of robust frameworks for assessing the economic value of healthcare interventions, thus enabling stakeholders to make informed decisions that enhance patient outcomes while managing costs effectively. Her leadership in cross-functional teams has facilitated collaborations that bridge gaps between clinical evidence and economic impact, influencing policy at multiple levels.
Nina is also known for her contributions to publications in health economics and outcomes research, where she shares her insights and findings with the wider community. Through her work, she has not only influenced healthcare practices but also inspired peers and up-and-coming experts to place a strong emphasis on economics in healthcare evaluation.
In her current role at Halozyme Therapeutics, Nina continues to lead innovative projects that push the boundaries of what is possible in health outcomes research, simultaneously balancing their economic viability. Her strategic vision and dedication to improving public health remain at the forefront of her professional endeavors.
